Methylphenobarbital

(Redirected from Mephobarbital)
Jump to: navigation, search
Methylphenobarbital
Methylphenobarbital.png
Clinical data
Pregnancy
category
  •  ?
Routes of
administration
?
ATC code
Legal status
Legal status
Pharmacokinetic data
Bioavailability?
Metabolism?
Elimination half-life?
Excretion?
Identifiers
CAS Number
PubChem CID
DrugBank
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC13H14N2O3
Molar mass246.3

WikiDoc Resources for Methylphenobarbital

Articles

Most recent articles on Methylphenobarbital

Most cited articles on Methylphenobarbital

Review articles on Methylphenobarbital

Articles on Methylphenobarbital in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Methylphenobarbital

Images of Methylphenobarbital

Photos of Methylphenobarbital

Podcasts & MP3s on Methylphenobarbital

Videos on Methylphenobarbital

Evidence Based Medicine

Cochrane Collaboration on Methylphenobarbital

Bandolier on Methylphenobarbital

TRIP on Methylphenobarbital

Clinical Trials

Ongoing Trials on Methylphenobarbital at Clinical Trials.gov

Trial results on Methylphenobarbital

Clinical Trials on Methylphenobarbital at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Methylphenobarbital

NICE Guidance on Methylphenobarbital

NHS PRODIGY Guidance

FDA on Methylphenobarbital

CDC on Methylphenobarbital

Books

Books on Methylphenobarbital

News

Methylphenobarbital in the news

Be alerted to news on Methylphenobarbital

News trends on Methylphenobarbital

Commentary

Blogs on Methylphenobarbital

Definitions

Definitions of Methylphenobarbital

Patient Resources / Community

Patient resources on Methylphenobarbital

Discussion groups on Methylphenobarbital

Patient Handouts on Methylphenobarbital

Directions to Hospitals Treating Methylphenobarbital

Risk calculators and risk factors for Methylphenobarbital

Healthcare Provider Resources

Symptoms of Methylphenobarbital

Causes & Risk Factors for Methylphenobarbital

Diagnostic studies for Methylphenobarbital

Treatment of Methylphenobarbital

Continuing Medical Education (CME)

CME Programs on Methylphenobarbital

International

Methylphenobarbital en Espanol

Methylphenobarbital en Francais

Business

Methylphenobarbital in the Marketplace

Patents on Methylphenobarbital

Experimental / Informatics

List of terms related to Methylphenobarbital

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Methylphenobarbital, also known as mephobarbital, (marketed in the US under the brand name Mebaral by Ovation) is a drug which is a barbiturate derivative.

Methylphenobarbital is used as a sedative, anxiolytic and anticonvulsant. It is the N-methylated analogue of phenobarbital, and has similar indications, therapeutic value, and tolerability.

Approval History

  • 1935 Mebaral was introduced by Winthrop Pharmaceuticals.
  • 2001 Methylphenobarbital discontinued in the UK.
  • 2003 Mebaral acquired by Ovation Pharmaceuticals (specialty pharmaceutical company who acquire underpromoted branded pharmaceutical products).

Overdose symptoms

Symptoms of overdose of metharbital include confusion, decrease in or loss of reflexes, somnolence, pyrexia, irritability, hypothermia, poor judgment, shortness of breath or slow/troubled breathing, slow heartbeat, slurred speech, staggering, trouble in sleeping, unusual movements of the eyes, weakness

References

  • The Treatment of Epilepsy 2nd Ed by S. D. Shorvon (Editor), David R. Fish (Editor), Emilio Perucca (Editor), W. Edwin Dodson (Editor). Published by Blackwell 2004. ISBN 0-632-06046-8

de:Methylphenobarbital fi:Metyylifenobarbitaali



Linked-in.jpg